Kristine Zanotti - Concepedia

Author

Kristine Zanotti

Also Known As

K M Zanotti, K ZANOTTI, K. M Zanotti, K. M. Zanotti, K. Zanotti, K.M. Zanotti, Kristin Zanotti, Kristine M. Zanotti, Kristine Zanotti, Margaret Markman

216

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

Cleveland Clinic Case Western Reserve University University Hospitals Cleveland Medical Center Cleveland Foundation University Hospitals of Cleveland

About

Kristine Zanotti is an author at Cleveland Clinic specializing in medicine, obstetrics, and gynecology oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	26	1.9K
2	Health Sciences	2	2	46
3	Public Health	2	2	528
4	Allergy	1	1	50
5	Exercise Physiology	1	1	20

Kristine Zanotti

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, Journal of the National Comprehensive Cancer Network Surgical OncologyCancer ManagementGynecologyPathologyGynecology Oncology	2023	506
Duration of Response to Second-Line, Platinum-Based Chemotherapy for Ovarian Cancer: Implications for Patient Management and Clinical Trial Design Maurie Markman, Jonathan Markman, Kenneth Webster, Journal of Clinical Oncology	2004	222
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance Anil Belur Nagaraj, Peronne Joseph, Olga Kovalenko, Oncotarget	2015	195
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021 Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Kristin Bradley, Journal of the National Comprehensive Cancer Network Uterine SarcomasNccn Guidelines® InsightsUterine FibroidsGynecological SurgeryMedicine	2021	169
Platinum/taxane‐based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma Amanda N. Fader, Richard D. Drake, David M. O’Malley, Cancer	2009	165
Carboplatin Skin Testing: A Skin-Testing Protocol for Predicting Hypersensitivity to Carboplatin Chemotherapy Kristine Zanotti, Lisa Rybicki, Alexander Kennedy, Journal of Clinical Oncology	2001	158
Expanded Experience With an Intradermal Skin Test to Predict for the Presence or Absence of Carboplatin Hypersensitivity Maurie Markman, Kristine Zanotti, Gertrude Peterson, Journal of Clinical Oncology	2003	151
The Use of Paclitaxel and Platinum-Based Chemotherapy in Uterine Papillary Serous Carcinoma Kristine Zanotti, Jerome L. Belinson, Alexander Kennedy, Gynecologic Oncology MedicineMetronomic TherapyPharmacologyGynecologyCancer Treatment	1999	128
Diagnosis and Management of Endometrial Hyperplasia Amy J. Armstrong, William W. Hurd, Sonia Elguero, Journal of Minimally Invasive Gynecology	2012	126
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC) Amanda N. Fader, David Starks, Paola A. Gehrig, Gynecologic Oncology Tumoral PathologyGynecological SurgeryCervical CancerPathologyGynecology	2009	121

Page 1